274 related articles for article (PubMed ID: 18026161)
1. Technology Insight: small, noncoding RNA molecules as tools to study and treat endocrine diseases.
Kolfschoten IG; Regazzi R
Nat Clin Pract Endocrinol Metab; 2007 Dec; 3(12):827-34. PubMed ID: 18026161
[TBL] [Abstract][Full Text] [Related]
2. Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs.
Yang M; Mattes J
Pharmacol Ther; 2008 Jan; 117(1):94-104. PubMed ID: 17928059
[TBL] [Abstract][Full Text] [Related]
3. Exploring microRNA functions in zebrafish.
Fjose A; Zhao XF
N Biotechnol; 2010 Jul; 27(3):250-5. PubMed ID: 20219709
[TBL] [Abstract][Full Text] [Related]
4. Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.
Kaucsár T; Rácz Z; Hamar P
Adv Drug Deliv Rev; 2010 Nov; 62(14):1390-401. PubMed ID: 20940025
[TBL] [Abstract][Full Text] [Related]
5. Rethinking the central dogma: noncoding RNAs are biologically relevant.
Robinson VL
Urol Oncol; 2009; 27(3):304-6. PubMed ID: 19414118
[TBL] [Abstract][Full Text] [Related]
6. [RNA interference (RNAi) and its therapeutic potential in cancer].
Vázquez-Vega S; Contreras-Paredes A; Lizano-Soberón M; Amador-Molina A; García-Carrancá A; Sánchez-Suárez LP; Benítez-Bribiesca L
Rev Invest Clin; 2010; 62(1):81-90. PubMed ID: 20415062
[TBL] [Abstract][Full Text] [Related]
7. Illuminating the silence: understanding the structure and function of small RNAs.
Rana TM
Nat Rev Mol Cell Biol; 2007 Jan; 8(1):23-36. PubMed ID: 17183358
[TBL] [Abstract][Full Text] [Related]
8. Antagomirzymes: oligonucleotide enzymes that specifically silence microRNA function.
Jadhav VM; Scaria V; Maiti S
Angew Chem Int Ed Engl; 2009; 48(14):2557-60. PubMed ID: 19229913
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological potential of RNAi--focus on miRNA.
Pfeifer A; Lehmann H
Pharmacol Ther; 2010 Jun; 126(3):217-27. PubMed ID: 20388525
[TBL] [Abstract][Full Text] [Related]
10. Prospects of RNA interference therapy for cancer.
Pai SI; Lin YY; Macaes B; Meneshian A; Hung CF; Wu TC
Gene Ther; 2006 Mar; 13(6):464-77. PubMed ID: 16341059
[TBL] [Abstract][Full Text] [Related]
11. RNA silencing: small RNA-mediated posttranscriptional regulation of mRNA and the implications for heart electropathophysiology.
Latronico MV; Condorelli G
J Cardiovasc Electrophysiol; 2009 Feb; 20(2):230-7. PubMed ID: 19017333
[TBL] [Abstract][Full Text] [Related]
12. Expression profiling of microRNAs in cancer cells: technical considerations.
Sioud M; Cekaite L
Methods Mol Biol; 2008; 439():179-90. PubMed ID: 18370103
[TBL] [Abstract][Full Text] [Related]
13. RNA interference in cancer.
Gartel AL; Kandel ES
Biomol Eng; 2006 Mar; 23(1):17-34. PubMed ID: 16466964
[TBL] [Abstract][Full Text] [Related]
14. Allele-specific RNA interference for neurological disease.
Rodriguez-Lebron E; Paulson HL
Gene Ther; 2006 Mar; 13(6):576-81. PubMed ID: 16355113
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in development and disease.
Erson AE; Petty EM
Clin Genet; 2008 Oct; 74(4):296-306. PubMed ID: 18713256
[TBL] [Abstract][Full Text] [Related]
16. Viral vector-mediated RNA interference.
Couto LB; High KA
Curr Opin Pharmacol; 2010 Oct; 10(5):534-42. PubMed ID: 20620113
[TBL] [Abstract][Full Text] [Related]
17. From sequence to function: using RNAi to elucidate mechanisms of human disease.
Wolters NM; MacKeigan JP
Cell Death Differ; 2008 May; 15(5):809-19. PubMed ID: 18202701
[TBL] [Abstract][Full Text] [Related]
18. Not miR-ly small RNAs: big potential for microRNAs in therapy.
Love TM; Moffett HF; Novina CD
J Allergy Clin Immunol; 2008 Feb; 121(2):309-19. PubMed ID: 18269923
[TBL] [Abstract][Full Text] [Related]
19. Small silencing RNAs: state-of-the-art.
Grimm D
Adv Drug Deliv Rev; 2009 Jul; 61(9):672-703. PubMed ID: 19427885
[TBL] [Abstract][Full Text] [Related]
20. RNA interference: a tool for querying nervous system function and an emerging therapy.
Davidson BL; Boudreau RL
Neuron; 2007 Mar; 53(6):781-8. PubMed ID: 17359914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
